Zurueck zur Suche

Reporte zur Charge EN939

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

34Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 4 IN 4 GA 3 AZ 3 MI 2 ID 2 NM 2 OH 1 TN 1 MA 1 FL 1 CT 1

VAERS 2684610

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

schwer
Staat
CT
Alter
17,0
Geschlecht
F
Eingang
21.09.2023
Impfdatum
15.09.2023
Beginn
15.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt
Fall Head injury Laboratory test Loss of consciousness Syncope

Symptomtext

After receiving Bexsero vaccine and finger stick, patient fainted/lost consciousness from sitting position on exam table and fell to the floor hitting the back of her head. Event was witnessed by nurse who said patient lost consciousness for 30-60 seconds, no seizure-like activity was witnessed. Nurse was walking out of the room when the patient fell off the exam table. When asked exactly what transpired, she explained that vaccine and labs were drawn without issue, patient verbalized that she was feeling fine and stayed in sitting position, nurse turned around to walk out of the room/back was to the patient and just as she was exiting the room patient slipped off the table (she believes the LOC occurred before making contact with the ground), height of the table from ground was ~30 inches.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N?A
Allergien
AUGMENTIN
Vorherige Impfungen
-

VAERS 2672319

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

schwer
Staat
IN
Alter
17,0
Geschlecht
M
Eingang
16.08.2023
Impfdatum
15.08.2023
Beginn
16.08.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Feeling hot Loss of consciousness

Symptomtext

Client passed out in clinic after receiving vaccines - though stated he had only 'eaten a donut at 8am'. Father of client called the following day to say that client also passed out at home at 1am - 'was feeling hot and fell over'.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
NKA
Vorherige Impfungen
-

VAERS 2529766

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

schwer
Staat
GA
Alter
16,0
Geschlecht
M
Eingang
13.12.2022
Impfdatum
12.12.2022
Beginn
12.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Erythema Face injury Fall Feeling hot Nausea Seizure Vomiting

Symptomtext

1640 male here to receive school vaccines Bexsero, HPV and Menquafi. Child was accompanied by his mother. Patient was very anxious prior to vaccine administration. RN gave child phycological reassurance. After child received 3rd vaccine (HPV), without warning he fell to the floor, hitting his face forward to the floor. The chair fell on top of the child. After the child hit the floor, he convulsed for 5 secs. RN and mother attempted to raise his head of off the floor. RN and mother held the child and yelled out for assistance. Tech took child's vitals. 106/64 - 78 RN and mother was able to get child in sitting position. Child vomited x2 C/O nausea. Cool wet compress applied to child's head, along with ice pack to back of his Neck. Clerk called emergency services. Fan turned on to cool child due to C/O feeling hot. Observed a reddened area about a half dollar sized circle to child's forehead. 0 hematoma or lump noted. Child was alert and talkative after in sitting position. Patient stated his Name, date, day of week and location correctly. Child denied dizziness or any weakness or headaches. EMT arrived @ 1:50pm. Vital Signs taken by EMT staff. EMT assisted child off of floor to standing position where his BP was taken again.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKOWN
Allergien
NONE NKDA
Vorherige Impfungen
-

VAERS 2659486

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

moderat
Staat
NE
Alter
17,0
Geschlecht
F
Eingang
21.07.2023
Impfdatum
13.07.2023
Beginn
13.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest pain Chills Computerised tomogram normal Fibrin D dimer increased Injection site irritation Laboratory test abnormal Pyrexia Tachycardia

Symptomtext

minor irritation at injection site; chills; fever/febrile; chest pain; Heart Rate 120; Abnormal Laboratory Results; This non-serious case was reported by a other health professional via call center representative and described the occurrence of injection site irritation in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number EN939, expiry date 31-OCT-2024) for prophylaxis. On 13-JUL-2023 10:30, the patient received Bexsero (injection, left deltoid). On 13-JUL-2023, 3 hrs after receiving Bexsero, the patient experienced chills (Verbatim: chills), fever (Verbatim: fever/febrile), chest pain (Verbatim: chest pain), tachycardia (Verbatim: Heart Rate 120) and lab test abnormal (Verbatim: Abnormal Laboratory Results). On 14-JUL-2023, the patient experienced injection site irritation (Verbatim: minor irritation at injection site). The patient was treated with ibuprofen and paracetamol (Tylenol). The outcome of the injection site irritation and lab test abnormal were unknown and the outcome of the chills, fever, chest pain and tachycardia were resolved. It was unknown if the reporter considered the injection site irritation, chills, fever, chest pain, tachycardia and lab test abnormal to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the injection site irritation, chills, fever, chest pain, tachycardia and lab test abnormal to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 14-JUL-2023 At approximately 1:00 pm patient's mother called at doctor's office and reported about chills, fever and chest pain, then gave patient Ibuprofen. Patient's mother was instructed to bring patient to office for assessment. Abnormal value reported by Physician Assistant as D-Dimer more than 5000. Patient given Tylenol at doctor's office. Symptoms resolved and patient was sent home in Mothers care. On the reporting day, the patient complained of minor irritation at injection site during follow up call. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
Test Date: 20230713; Test Name: Blood Pressure; Result Unstructured Data: (Test Result:116/80,Unit:unknown,Normal Low:,Normal High:); Test Date: 20230713; Test Name: D-Dimer; Result Unstructured Data: (Test Result:D-Dimer more than 5000,Unit:unknown,Normal Low:,Normal High:); Test Date: 20230713; Test Name: computed tomography; Result Unstructured Data: (Test Result:R/O pulmonary emboli,Unit:unknown,Normal Low:,Normal High:); Test Date: 20230713; Test Name: Heart rate; Result Unstructured Data: (Test Result:120,Unit:unknown,Normal Low:,Normal High:); Test Date: 20230713; Test Name: Pulse Oximetry; Test Result: 100 %; Test Date: 20230713; Test Name: Respirations; Result Unstructured Data: (Test Result:20,Unit:unknown,Normal Low:,Normal High:); Test Date: 20230713; Test Name: body temperature; Result Unstructured Data: (Test Result:100.8,Unit:degree F,Normal Low:,Normal High:)
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2628370

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

moderat
Staat
TX
Alter
16,0
Geschlecht
F
Eingang
08.05.2023
Impfdatum
04.05.2023
Beginn
04.05.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Injection site nodule Injection site swelling Injection site warmth Loss of personal independence in daily activities Mobility decreased Pain Pain in extremity Peripheral swelling Pyrexia

Symptomtext

She had a reaction the first time she had the vaccine but that was also with the boosters. She got her vaccine, 20 minutes after the vaccine she started complaining that her arm was getting sore. She said that it felt like she had been bruised and could hardly move her arm. The next morning her arm was swollen, it went down halfway down her arm from the shoulder was puffy and swollen and has a knot at the injection site. It was hot to touch, fever. She was complaining with body aches, especially in her thighs and hips area, and then down her arm. The aching was in her shoulders, like she had been running high fever and affecting her joints. She said it felt like when she had COVID. She missed school the next day and still cannot pick up things with that arm as it is still swollen and puffed up. Mother called the doctor, they did not tell her to bring her in and that there was really not much to do for her and to give her Ibuprofen and Tylenol and mother believes she has been taking Ibuprofen and ice packs.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None.
Vorgeschichte
ADD.
Andere Medikamente
Cetirizine, Montelukast, Buspar, Pepcid.
Allergien
None.
Vorherige Impfungen
Prior meningitis vaccine, but took with COVID vaccines. She had similar issues with the knot but nothing that has lasted this l

VAERS 2566891

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

moderat
Staat
-
Alter
17,0
Geschlecht
M
Eingang
24.01.2023
Impfdatum
24.01.2023
Beginn
24.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Palpitations Visual impairment

Symptomtext

pt c/o heart racing and vision going black

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2549781

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge en939

moderat
Staat
IN
Alter
18,0
Geschlecht
F
Eingang
04.01.2023
Impfdatum
29.12.2022
Beginn
29.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyspnoea Electrocardiogram abnormal Sinus tachycardia Tachycardia Urticaria

Symptomtext

Patient developed hives within 5 hours of administration on bilateral arms and chest and then developed a feeling of shortness of breath and tachycardia rate of 108. Patient was given 40 mg Solumedrol IM in the office. Given 0.3 mg IM epinephrine by EMS and taken to the ED for further evaluation, where she was given oral Benadryl and Pepcid for full anaphylaxis prevention treatment and monitored for approximately 2 hours and then discharged to home in stable and improved condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
EKG: Sinus Tachycardia, otherwise normal. Vital Signs: Temp 97.5, Pulse 108, RR 22, BP 108/61, oxygen 98 % on Room Air
Aktuelle Erkrankungen
GERD
Vorgeschichte
None
Andere Medikamente
Sprintec 28, 0.25-35 mg-mcg, 1 tablet daily Omeprazole, 20 mg, delayed release daily
Allergien
NKA
Vorherige Impfungen
-

VAERS 2692099

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
LA
Alter
16,0
Geschlecht
F
Eingang
06.10.2023
Impfdatum
06.10.2023
Beginn
06.10.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood test normal Crying Headache Hyporesponsive to stimuli Pallor Urine analysis normal

Symptomtext

Patient was fine in the clinic and waited 15 minutes before leaving clinic after she received the injection. Caregiver called the clinic at 10:19 AM and stated her daughter was having a severe Headache. She stated she was crying stating her head hurt so bad. Caregiver gave child 3 ibuprofen and then was going to take the child to the MD office and she stated that her daughter the patient turned white and was very slow to respond. She went to the ER and said upon admission her B/P was 124/46.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
All the ER nurse and the caregiver stated was that blood work was collected along with a urine sample and the MD stated all the results were normal. They also stated that she received on 1000ml of Normal Saline per IV. Caregiver stated the patient was discharged at approx. 1:15PM. She stated the patient still complained of a H/A, but that it was much better.
Aktuelle Erkrankungen
None
Vorgeschichte
Iron Deficiency Anemia
Andere Medikamente
Ferous Sol 325 mg daily, Multivitamin, Probiotic, Vit C, and Electrolytes Tablet
Allergien
PCN
Vorherige Impfungen
-

VAERS 2662703

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
MN
Alter
17,0
Geschlecht
M
Eingang
28.07.2023
Impfdatum
25.07.2023
Beginn
25.07.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Injection site erythema Injection site induration Injection site swelling Injection site warmth Pain

Symptomtext

Patient with extreme fatigue day after vaccine. Large red bump at site of injection, hot to touch, hard. Arm very sore to move.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Elevated cholesterol, GERD, asthma, ADHD, Autism
Andere Medikamente
escitalopram montelukast trazodone
Allergien
Amoxicillin clavulanic acid cefprozil cephalexin Animals, dust mites
Vorherige Impfungen
-

VAERS 2643797

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge En939

mild
Staat
AZ
Alter
18,0
Geschlecht
F
Eingang
10.06.2023
Impfdatum
06.06.2023
Beginn
06.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Fatigue Headache Hot flush Injection site pain Nausea Rash

Symptomtext

Fatigue, headache, soreness at injection site started almost right away. Followed by hot flashes/chills and nausea later in the day. 5 days later a non itchy rash has appeared on face. Nausea, head ache, and Fatigue are better but still present after 5 days. Taking Tylenol or ibuprofen to manage soreness and headache. Benedryl for the rash

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Vit c, zinc, allegra
Allergien
None
Vorherige Impfungen
-

VAERS 2629249

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
CA
Alter
16,0
Geschlecht
F
Eingang
09.05.2023
Impfdatum
02.05.2023
Beginn
02.05.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Contusion Erythema Feeling hot Mass Pain

Symptomtext

Redness/warmth/pain later that day with lump and bruising after; prescribed Benadryl & ibuprofen

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
-
Vorgeschichte
Anxiety/depression Concern for obstructive sleep apnea
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2615672

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
GA
Alter
17,0
Geschlecht
F
Eingang
15.04.2023
Impfdatum
14.03.2023
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Myalgia Pyrexia Rash Rash erythematous

Symptomtext

Fever; Chills; Pain in left deltoid; Red rash in left arm; This non-serious case was reported by a nurse via sales rep and described the occurrence of fever in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number EN939, expiry date 31-OCT-2024) for prophylaxis. On 14-MAR-2023, the patient received Bexsero (left deltoid). On 15-MAR-2023, 1 days after receiving Bexsero, the patient experienced fever (Verbatim: Fever), chills (Verbatim: Chills) and localized muscle pain (Verbatim: Pain in left deltoid). On 16-MAR-2023, the patient experienced red rash (Verbatim: Red rash in left arm). The outcome of the fever, chills, localized muscle pain and red rash were resolved (duration 24 hrs). It was unknown if the reporter considered the fever, chills, localized muscle pain and red rash to be related to Bexsero and Bexsero Pre-Filled Syringe Device. It was unknown if the company considered the fever, chills, localized muscle pain and red rash to be related to Bexsero and Bexsero Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt date: 10-APR-2023 Reporter was a nurse Nurse reported that female patient received Bexsero vaccine in her left deltoid then 24 hours later the patient started with fever, chills and pain in left deltoid. Reporter also informed 48 hours after the administration the patient experienced a red rash in her left deltoid. All symptoms went away in 24 hours. The reporter was consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2607019

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
WA
Alter
17,0
Geschlecht
F
Eingang
30.03.2023
Impfdatum
28.03.2023
Beginn
29.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Urticaria

Symptomtext

Urticaria

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Viral URI with cough (COVID and Flu PCR negative) 3 weeks prior, symptoms had resolved
Vorgeschichte
None
Andere Medikamente
Aviane (levonogestrel-ethinyl estradiol oral contraceptive) and albuterol inhaler PRN
Allergien
Adhesives
Vorherige Impfungen
-

VAERS 2604094

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
AZ
Alter
16,0
Geschlecht
F
Eingang
27.03.2023
Impfdatum
21.02.2023
Beginn
21.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia

Symptomtext

Left shoulder pain for approximately 4 days. She took Tylenol for pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 2600088

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
IN
Alter
12,0
Geschlecht
M
Eingang
21.03.2023
Impfdatum
20.03.2023
Beginn
01.03.2023
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity

Symptomtext

Per father, Pt experienced soreness in both arms with more in the right arm than the left last night. His son took Tylenol for discomfort in the evening and went to bet with no issues. This morning, he said the son had no complaints before going to school.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
-
Allergien
none
Vorherige Impfungen
-

VAERS 2598587

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge En939

mild
Staat
KY
Alter
18,0
Geschlecht
F
Eingang
17.03.2023
Impfdatum
15.03.2023
Beginn
16.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Injection site warmth

Symptomtext

Pt returned to clinic 2 days after vaccination and had redness, swelling, warmth to Left Deltoid Region where she received vaccine. Denies other symptoms

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
PCN
Vorherige Impfungen
-

VAERS 2597209

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
AZ
Alter
16,0
Geschlecht
F
Eingang
15.03.2023
Impfdatum
08.03.2023
Beginn
09.03.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Induration Pain in extremity Tenderness

Symptomtext

Left arm with pain, tenderness, and induration persisting one week after vaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
back pain
Vorgeschichte
obesity, asthma, seborrheic dermatitis
Andere Medikamente
Vitamin D3 50mcg capsule daily
Allergien
Penicillin, cefdinir
Vorherige Impfungen
-

VAERS 2577175

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
PR
Alter
16,0
Geschlecht
M
Eingang
07.02.2023
Impfdatum
23.01.2023
Beginn
24.01.2023
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye swelling Pain in extremity

Symptomtext

Mother refers "adolescent remained with pain in arm and gave Advil. 30 minutes after Advil, eyes became swollen. Notified doctor but an appointment was given for 1/25/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
Mother took to doctor consult, already better as observed by doctor.
Aktuelle Erkrankungen
reflux
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2567825

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
OH
Alter
17,0
Geschlecht
F
Eingang
25.01.2023
Impfdatum
19.01.2023
Beginn
21.01.2023
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Ear pain Eye pruritus Peripheral swelling Pruritus Pyrexia Rash erythematous Swelling face Swelling of eyelid

Symptomtext

Right arm swelling (present but improved at time of presentation), right arm itching (no longer present at time of presentation), right arm erythematous rash (no longer present at time of presentation), face & eyelid swelling (present but improved at time of presentation), fever for 2 days (had resolved as of presentation), ear pain (bilateral, present at time of presentation), itchy eyes (resolved at time of presentation)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ear pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2530990

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

mild
Staat
FL
Alter
16,0
Geschlecht
M
Eingang
14.12.2022
Impfdatum
12.12.2022
Beginn
13.12.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Rash

Symptomtext

The patient presented a rash over his chest, back, and both arms. No respiratory distress. He was given a Benadryl 20 mg around 04:15 pm and was then taken to the ER for further evaluation. He has been prescribed Prednisone 20 mg to be taken as follows: 2 tabs (40 mg total) PO, one time each day for 5 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2727058

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
-
Alter
12,0
Geschlecht
F
Eingang
22.12.2023
Impfdatum
14.11.2023
Beginn
14.11.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

Vaccine was given too early. No signs and symptoms of anyphylaxis, no excessive redness or swelling, no hospitalization.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670087

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
IN
Alter
11,0
Geschlecht
F
Eingang
11.08.2023
Impfdatum
10.08.2023
Beginn
10.08.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Unevaluable event

Symptomtext

Patient received 4 vaccines during appointment. Patient's guardian, authorized 2 of the 4 vaccinations (Tdap and Meningococcal). Patient's guardian was present during administration of the vaccines. After the patient and her guardian left the office, it was found that the guardian only authorized the 2 vaccines. Health Department left voicemail on guardian's cell at 4:31 PM. Health Department spoke to guardian on Friday, August 11 at 8:25 AM. Guardian stated outrage regarding the administering of the 2 other vaccinations and requested documentation regarding her consent. Side effects and vaccine appropriateness explained. Requested documentation and educational materials were placed in the mail today at 9:05 AM.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2664281

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
NM
Alter
13,0
Geschlecht
M
Eingang
01.08.2023
Impfdatum
25.07.2023
Beginn
01.08.2023
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

There is no adverse reaction to report. The pt was given Bexsero as their first meningococcal vaccine ever instead of MCV4 and he is under the recommended age of 16 for Bexsero

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2664275

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
NM
Alter
15,0
Geschlecht
F
Eingang
01.08.2023
Impfdatum
25.07.2023
Beginn
01.08.2023
Tage bis Beginn
7,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

No adverse reaction has happened. The pt was given this as a first dose of meningococcal vaccine instead of the MCV4. This pt is also under the recommended age of 16 for Bexsero

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2649868

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
MA
Alter
18,0
Geschlecht
M
Eingang
27.06.2023
Impfdatum
23.06.2023
Beginn
23.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

This patient received the Bexsero State vaccine instead of the Private vaccine. A private Bexsero vaccine was transferred to the state stock to replace the dose. Bexsero state vaccine given: Lot # EN939 Expiration date: 10/31/2024 NDC:58160-976-02 Manufacturer: GlaxoSmithKline Bexsero Private vaccine transferred to state stock: Lot # J52PN Expiration date: 03/31/2024 NDC: 58160-976-02 Manufacturer: GlaxoSmithKline

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2649386

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
ID
Alter
18,0
Geschlecht
F
Eingang
26.06.2023
Impfdatum
07.04.2023
Beginn
07.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products

Symptomtext

Patient received Bexsero as second dose for Men B. Original dose was Trumenba. Patient will need second dose of either Bexero or Trumenba to complete the series

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Depression
Andere Medikamente
Sertraline
Allergien
NKA
Vorherige Impfungen
-

VAERS 2641698

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
TX
Alter
18,0
Geschlecht
F
Eingang
06.06.2023
Impfdatum
06.06.2023
Beginn
06.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administration error

Symptomtext

Patient has severe allergy to Latex. Men B (Bexsero) was administered in an error. Patient called to ensure that she did not have any adverse reaction at 1:07 pm on 06/06/2023. Pt denied any adverse reaction at the time of call.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None needed
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Allergies to Penicillin- Anaphylaxis Allergies to Latex-Shortness of breath
Vorherige Impfungen
-

VAERS 2635451

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
GA
Alter
16,0
Geschlecht
M
Eingang
23.05.2023
Impfdatum
20.04.2023
Beginn
21.04.2023
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Peripheral swelling

Symptomtext

Patient's mother called the office stating patient's arm was swollen. Denied redness or rash.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Peripheral swelling
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2611989

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
TN
Alter
0,2
Geschlecht
M
Eingang
07.04.2023
Impfdatum
13.03.2023
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

No adverse events incorrect vaccine given - Mother - contacted & informed - S&S listed of reaction - Directions in care of inj site. Advised to take to ER if needed or RTC if so. 3-15-23 - Mother states child is doing well.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2611253

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
MI
Alter
11,0
Geschlecht
M
Eingang
07.04.2023
Impfdatum
06.04.2023
Beginn
06.04.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Patient inadvertently received MenB vaccine. Patient was not due for Men B, and just due for Meningococcal Conjugate. Men B was pulled from refrigerator and administered to patient. Patient received planned vaccines of Tdap, Meningococcal Conjugate and HPV. Patient was notified in person and mother was notified via phone. Updated system , VIS sheets, and a copy of signed vaccine consent sent home with patient. Patient experienced no symptoms and returned to class 15 minutes after vaccine administration. Snack and water eaten by student while waiting and ice pack applied to arms . Clinical supervisor notified, debriefing scheduled to discuss vaccine safety and administration techniques to prevent future adverse events.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
ADD/ADHD : Oppositional defiant disorder
Andere Medikamente
Multi-Vitamin and Zyrtec as needed
Allergien
Seasonal allergies
Vorherige Impfungen
-

VAERS 2611231

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
ID
Alter
17,0
Geschlecht
F
Eingang
06.04.2023
Impfdatum
06.04.2023
Beginn
06.04.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered Vaccination error

Symptomtext

Bivalent vaccine incorrectly administered for the primary series.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2602069

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
TX
Alter
17,0
Geschlecht
F
Eingang
22.03.2023
Impfdatum
24.02.2023
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy No adverse event

Symptomtext

No adverse reaction report. Dr spoke with patient and explained theoretical side effects of administering live vaccines during pregnancy. Patient follow up with O.B. on 3/13/23, 3/10/23. Next appt 4/6/23.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKA
Vorherige Impfungen
-

VAERS 2594739

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
TX
Alter
16,0
Geschlecht
F
Eingang
10.03.2023
Impfdatum
06.03.2023
Beginn
08.03.2023
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Administration site erythema Administration site reaction Administration site swelling Muscular weakness

Symptomtext

Patient presented to clinic 2 days after vaccine administration with redness, swelling and weakness on arm where injection was administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Administration site erythema
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 2497632

NOVARTIS VACCINES AND DIAGNOSTICS · MENINGOCOCCAL B (BEXSERO) · Charge EN939

gering
Staat
MI
Alter
13,0
Geschlecht
M
Eingang
03.11.2022
Impfdatum
01.11.2022
Beginn
01.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administration error Wrong product administered

Symptomtext

The patient was gave a Meningococcal Group B , instead of Meningococcal Conjugate (MCV4).. There has been no treatment, the parent has been notified along wit a vaccine administration error report has been submitted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-